Dibenzo[1,6]naphthyridindiones as modified quinolone antibacterials

[1]  D. Wigley,et al.  Molecular mechanisms of durg inhibition of DNA gyrase , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  L. Hurley,et al.  Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. , 1995, Journal of medicinal chemistry.

[3]  B. Gatto,et al.  On the mechanism of action of quinolone drugs. , 1993, Trends in microbiology.

[4]  D. Hooper,et al.  The fluoroquinolones: Clinical and laboratory considerations , 1992 .

[5]  D. Chu,et al.  Practical Synthesis of Iminochlorothioformates: Application of Iminochlorothioformates in the Synthesis of Novel 2,3,4,9- Tetrahydroisothiazolo(5,4-b)(1,8)naphthyridine-3,4-diones and 2,3,4,9- Tetrahydroisothiazolo(5,4-b)quinoline-3,4-dione Derivatives. , 1991 .

[6]  D. Chu.  Syntheses of 6-fluoro-7-piperazin-1-yl-9-cyclopropyl-2,3,4,9-tetrahydroisothiazolo[5,4-b]quinoline-3,4-dione and 6-fluoro-7-piperazin-1-yl-9-p-fluorophenyl-2,3,4,9-tetrahydroisothiazolo[5,4-b]quinoline-3,4-dione † , 1990 .

[7]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.

[8]  T J O'Donnell,et al.  Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model. , 1989, Biochemistry.

[9]  J. Baranowski,et al.  Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. , 1989, Biochemistry.

[10]  G. Segre,et al.  Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids. , 1987, Journal of medicinal chemistry.